Literature DB >> 9664967

Total ureteral replacement by subcutaneous pyelovesical bypass in ureteral necrosis after renal transplantation.

F Desgrandchamps1, A Duboust, P Teillac, J M Idatte, A Le Duc.   

Abstract

OBJECTIVES: Ureteral necrosis is a rare complication of renal transplantation, and is seldom cured by endoscopic management alone. To avoid the potential hazard to the graft created by an open ureteral reconstruction in cases of renal transplant ureteral necrosis, we have appiled a new minimally invasive technique of total ureteral replacement, initially described for the palliative treatment of ureteral obstructions. The subcutaneous bypass technique is based on the use of a silicone-PTFE-bonded tube tunnelled underneath the skin.
METHODS: Total ureteral replacement by subcutaneous pyelovesical bypass was performed in three renal transplant patients (two men and one woman; mean age 41 years, (range 23-58) years with ureteral necrosis after failure of primary endoscopic treatment. The ureteral lesion was distal necrosis in two patients, and a total necrosis in the other. Under general anaesthesia and fluoroscopic guidance, a percutaneous tract was created and progressively dilated. The ureteral prosthesis was introduced into the pyelocaliceal cavities through a 30 F Amplatz sheet, then subcutaneously tracked down to the suprapubic area, and introduced into the bladder via a short incision.
RESULTS: There was no operative or postoperative morbidity. There was no obstruction, dislodgement or encrustation of the prosthesis. There were no bladder-related symptoms, or clinical reflux, and no abdominal wall complications. An asymptomatic episode of lower urinary tract infection (Staphylococcus epidermidis) was observed in the female patient. All the grafts were functioning with fine pyelocaliceal cavities, with a mean follow-up of 32 months (13-69 months).
CONCLUSION: Total ureteral replacement by subcutaneous pyelovesical bypass is a simple and safe technique of ureteral reconstruction in renal transplantation. Late encrustation of the prosthesis may occur, and the prosthesis may need to be changed in such cases. Subcutaneous pyelovesical bypass can be regarded as an alternative to an open procedure to treat ureteral necrosis after renal transplantation.

Entities:  

Mesh:

Year:  1998        PMID: 9664967     DOI: 10.1007/s001470050449

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  4 in total

1.  [Prosthetic pyelovesical and pyelocutanous bypass. A palliative therapy concept in tumor-induced chronic hydronephprosis].

Authors:  H Loertzer; A Jurczok; S Wagner; P Fornara
Journal:  Urologe A       Date:  2003-05-27       Impact factor: 0.639

2.  Simultaneous bilateral subcutaneous pyelovesical bypass as a salvage procedure in refractory retroperitoneal fibrosis.

Authors:  Nicholas Haddad; Sero Andonian; Maurice Anidjar
Journal:  Can Urol Assoc J       Date:  2013 May-Jun       Impact factor: 1.862

3.  Preperitoneal Surgical Approach to Treat Vesicoureteral Anastomotic Leakage, Distal Stenosis or Reflux After Kidney Transplantation.

Authors:  Tom Darius; Antoine Buemi; Laurent Coubeau; Nada Kanaan; Pierre Goffette; Michel Mourad
Journal:  World J Surg       Date:  2018-03       Impact factor: 3.352

4.  [Long-term results for subcutaneous Detour® prosthesis for ureteral obstruction: experiences of implantation, aftercare and management of complications].

Authors:  A Janitzky; J Borski; M Porsch; J J Wendler; D Baumunk; U-B Liehr; M Schostak
Journal:  Urologe A       Date:  2012-12       Impact factor: 0.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.